🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07058935
Recruiting Observational

The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

NCT07058935 · tracked via the Priya Life Science India tracker
Sponsor
National Heart Centre Singapore
Phase
Observational
Started
2025-03-17
Last updated
2025-07-10

Condition(s) studied

Valve Disease, Heart

Study summary

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

Eligibility

Sex
ALL
Min age
21 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 21 2. Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective) Exclusion Criteria: 1. Active endocarditis 2. Any other conditions which investigator deems unsuitable for participation.

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
John Hunter Hospital New Lambton Heights Australia Not Yet Recruiting
Prince of Wales Hospital Hong Kong Hong Kong Not Yet Recruiting
Queen Elizabeth Hospital Hong Kong Hong Kong Not Yet Recruiting
MGM Healthcare Pvt Ltd Chennai Tamil Nadu Not Yet Recruiting
The Madras Medical Mission Chennai Tamil Nadu Not Yet Recruiting
Waikato Hospital Hamilton New Zealand Not Yet Recruiting
National Heart Centre Singapore Singapore Singapore Recruiting
Ramathibodi Hospital Bangkok Thailand Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07058935 on ClinicalTrials.gov ↗ ← All trials in India